"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","22/33","499/2914",2.73320832076366e-10,1.04408557853172e-07,6.87617672276332e-08,"CASP1/CDK8/CTNNB1/E2F1/EGFR/EP300/MAML1/MYB/NOTCH1/NR3C1/NR4A1/PARP1/PIDD1/SMAD4/TP53/FOXO1/LEF1/STAT1/TP73/POU2F1/MEF2C/NR2F1",22
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","21/33","481/2914",1.265386909951e-09,2.41688899800641e-07,1.59172353409626e-07,"CASP1/CDK8/CTNNB1/E2F1/EGFR/EP300/MAML1/MYB/NOTCH1/NR3C1/NR4A1/PARP1/PIDD1/SMAD4/TP53/FOXO1/LEF1/STAT1/TP73/MEF2C/NR2F1",21
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","6/33","27/2914",3.27597810769765e-07,4.17141212380168e-05,2.74722374645522e-05,"E2F1/EP300/MYB/STAT3/LEF1/CEBPB",6
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","9/33","104/2914",1.25466503697921e-06,7.67935592780143e-05,5.05749811723489e-05,"CDK8/E2F1/EGFR/EP300/MAML1/NOTCH1/TP53/STAT1/HIF1A",9
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/33","53/2914",1.30349355199426e-06,7.67935592780143e-05,5.05749811723489e-05,"CTNNB1/EP300/MAML1/NOTCH1/SMAD4/TP53/LEF1",7
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","16/33","397/2914",1.34040561150467e-06,7.67935592780143e-05,5.05749811723489e-05,"CDK8/CTNNB1/E2F1/EGFR/EP300/MAML1/MYB/NOTCH1/SMAD4/STAT3/NFKB1/FOXO1/LEF1/RELA/MEF2C/CEBPB",16
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","6/33","34/2914",1.40721181923063e-06,7.67935592780143e-05,5.05749811723489e-05,"CHUK/CTNNB1/EP300/PRKDC/NFKB1/RELA",6
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","5/33","23/2914",3.95887697755508e-06,0.000180753911827422,0.000119041567723213,"E2F1/EP300/MAML1/NOTCH1/TP53",5
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","4/33","11/2914",4.25860001687643e-06,0.000180753911827422,0.000119041567723213,"CASP1/PIDD1/TP53/TP73",4
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","5/33","29/2914",1.33119440788884e-05,0.000508516263813537,0.000334900487879403,"E2F1/EP300/MAML1/NOTCH1/TP53",5
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","12/33","268/2914",1.74782155872705e-05,0.000606970759485212,0.000399741007211258,"CDK8/CHUK/CTNNB1/EGFR/EP300/MAML1/NOTCH1/NR4A1/SMAD4/STAT3/FOXO1/STAT1",12
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","13/33","332/2914",2.95458277102854e-05,0.000940542182110751,0.00061942568620686,"CASP1/CHUK/HMGB1/LIF/STAT3/TP53/NFKB1/FOXO1/STAT1/HIF1A/RELA/POU2F1/MEF2C",13
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","4/33","18/2914",3.73381933130327e-05,0.00109716844965988,0.000722577182333184,"EP300/MAML1/NOTCH1/STAT1",4
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","5/33","37/2914",4.58089172065497e-05,0.00124992902663586,0.00082318279792221,"EGFR/EP300/MAML1/NOTCH1/STAT1",5
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","7/33","94/2914",6.24893200325852e-05,0.00151309678141969,0.000996500773654744,"LIF/STAT3/TP53/FOXO1/STAT1/HIF1A/POU2F1",7
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","5/33","40/2914",6.7497215752951e-05,0.00151309678141969,0.000996500773654744,"CDK8/EP300/MAML1/NOTCH1/HIF1A",5
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","5/33","40/2914",6.7497215752951e-05,0.00151309678141969,0.000996500773654744,"CDK8/EP300/NFKB1/RELA/CEBPB",5
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","4/33","21/2914",7.12977540983101e-05,0.00151309678141969,0.000996500773654744,"CHUK/HMGB1/NFKB1/RELA",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","4/33","24/2914",0.000123584307876694,0.00248469503204722,0.00163637947825651,"EP300/MAML1/NOTCH1/FOXO1",4
"R-HSA-1643685","R-HSA-1643685","Disease","14/33","443/2914",0.000145586213129756,0.00277790120920322,0.00182948026729008,"CDK8/CHUK/CTNNB1/EGFR/EP300/MAML1/NOTCH1/NR4A1/SMAD4/STAT3/NFKB1/FOXO1/STAT1/RELA",14
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/33","187/2914",0.000152711846579235,0.00277790120920322,0.00182948026729008,"E2F1/EP300/NR3C1/STAT3/TP53/NFKB1/HIF1A/RELA/CEBPB",9
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/33","189/2914",0.00016581114118245,0.00287908436053163,0.00189611783457443,"E2F1/EP300/NR3C1/STAT3/TP53/NFKB1/HIF1A/RELA/CEBPB",9
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","4/33","27/2914",0.000199275796232895,0.00330971105047677,0.00217972152401198,"CHUK/HMGB1/NFKB1/RELA",4
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","6/33","82/2914",0.000249061878214357,0.00396423489491184,0.00261078021461541,"CASP1/CHUK/HMGB1/STAT3/NFKB1/RELA",6
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","3/33","12/2914",0.000271724408720262,0.00399225862042846,0.00262923618154423,"EP300/MAML1/NOTCH1",3
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","3/33","12/2914",0.000271724408720262,0.00399225862042846,0.00262923618154423,"CASP1/NFKB1/RELA",3
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","4/33","30/2914",0.000303803892414143,0.00429826247785935,0.00283076531333256,"CASP1/PIDD1/TP53/TP73",4
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","3/33","13/2914",0.000350517585572624,0.00478206134602651,0.00314938732901718,"EP300/MAML1/NOTCH1",3
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","5/33","64/2914",0.000644363406511891,0.00826327407936013,0.00544205705419419,"CDK8/EP300/MAML1/NOTCH1/HIF1A",5
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","3/33","16/2914",0.000670579833665351,0.00826327407936013,0.00544205705419419,"CHUK/NFKB1/RELA",3
"R-HSA-622312","R-HSA-622312","Inflammasomes","3/33","16/2914",0.000670579833665351,0.00826327407936013,0.00544205705419419,"CASP1/NFKB1/RELA",3
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/33","99/2914",0.00069483770680912,0.00829462512503387,0.00546270433971644,"E2F1/STAT3/TP53/NFKB1/RELA/CEBPB",6
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","5/33","66/2914",0.000743177886608368,0.00860284705104233,0.00566569425516428,"CHUK/EP300/HMGB1/NFKB1/RELA",5
"R-HSA-109581","R-HSA-109581","Apoptosis","6/33","101/2914",0.000773281337186054,0.00868804325897272,0.00572180308320331,"CTNNB1/E2F1/HMGB1/STAT3/TP53/TP73",6
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/33","17/2914",0.000808002503868657,0.00881877018508077,0.00580789769698072,"EP300/MAML1/NOTCH1",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","6/33","103/2914",0.000858449712810543,0.0091091052859341,0.00599910764215555,"CTNNB1/E2F1/HMGB1/STAT3/TP53/TP73",6
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","3/33","19/2914",0.00113373857062819,0.0111048239482043,0.00731345528691328,"CHUK/NFKB1/RELA",3
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","3/33","19/2914",0.00113373857062819,0.0111048239482043,0.00731345528691328,"EP300/NFKB1/RELA",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/33","19/2914",0.00113373857062819,0.0111048239482043,0.00731345528691328,"NR3C1/SMAD4/FOXO1",3
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","3/33","20/2914",0.00132354290761968,0.0123315461148956,0.00812135442672924,"CHUK/NFKB1/RELA",3
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","3/33","20/2914",0.00132354290761968,0.0123315461148956,0.00812135442672924,"CHUK/NFKB1/RELA",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/33","45/2914",0.00146521587968608,0.0133264872866686,0.00877660639711713,"STAT3/NFKB1/RELA/CEBPB",4
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/33","78/2914",0.00159339071279907,0.0135261167175388,0.00890807907272465,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/33","78/2914",0.00159339071279907,0.0135261167175388,0.00890807907272465,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/33","78/2914",0.00159339071279907,0.0135261167175388,0.00890807907272465,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","4/33","47/2914",0.00172626179868557,0.0140109250667666,0.00922736591611246,"EGFR/NR3C1/STAT3/HIF1A",4
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","4/33","47/2914",0.00172626179868557,0.0140109250667666,0.00922736591611246,"EGFR/NR3C1/STAT3/HIF1A",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","3/33","22/2914",0.00176053508692355,0.0140109250667666,0.00922736591611246,"CTNNB1/EP300/LEF1",3
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","4/33","48/2914",0.0018682252415826,0.0143569685310965,0.00945526447763035,"CASP1/CHUK/NFKB1/RELA",4
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","3/33","23/2914",0.00200904329813786,0.0143569685310965,0.00945526447763035,"LIF/STAT3/STAT1",3
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/33","49/2914",0.00201812067307788,0.0143569685310965,0.00945526447763035,"E2F1/STAT3/TP53/TP73",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","4/33","49/2914",0.00201812067307788,0.0143569685310965,0.00945526447763035,"EP300/NR3C1/SMAD4/FOXO1",4
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/33","83/2914",0.00210466397803383,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/33","84/2914",0.00221986451438092,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/33","84/2914",0.00221986451438092,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","3/33","24/2914",0.00227839458246088,0.0143569685310965,0.00945526447763035,"CHUK/NFKB1/RELA",3
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","3/33","24/2914",0.00227839458246088,0.0143569685310965,0.00945526447763035,"CHUK/NR4A1/FOXO1",3
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","4/33","51/2914",0.00234261672311178,0.0143569685310965,0.00945526447763035,"CDK8/EP300/MAML1/NOTCH1",4
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","4/33","51/2914",0.00234261672311178,0.0143569685310965,0.00945526447763035,"CDK8/EP300/MAML1/NOTCH1",4
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","4/33","51/2914",0.00234261672311178,0.0143569685310965,0.00945526447763035,"CDK8/EP300/MAML1/NOTCH1",4
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","4/33","51/2914",0.00234261672311178,0.0143569685310965,0.00945526447763035,"CDK8/EP300/MAML1/NOTCH1",4
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","4/33","51/2914",0.00234261672311178,0.0143569685310965,0.00945526447763035,"CDK8/EP300/MAML1/NOTCH1",4
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/33","86/2914",0.00246406243835789,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/33","86/2914",0.00246406243835789,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/33","86/2914",0.00246406243835789,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","4/33","52/2914",0.00251766904588671,0.0143569685310965,0.00945526447763035,"EP300/NR3C1/HIF1A/MEF2C",4
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/33","87/2914",0.00259327442053837,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/33","87/2914",0.00259327442053837,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/33","87/2914",0.00259327442053837,0.0143569685310965,0.00945526447763035,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/33","90/2914",0.00301065663196936,0.0161981807522858,0.0106678567092761,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/33","90/2914",0.00301065663196936,0.0161981807522858,0.0106678567092761,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","4/33","57/2914",0.0035298792485183,0.0187279704574166,0.0123339348011093,"CHUK/HMGB1/NFKB1/RELA",4
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/33","29/2914",0.00395766925047827,0.0207099952559274,0.0136392638913382,"E2F1/TP53/TP73",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/33","30/2914",0.00436365429026318,0.0225258910659532,0.0148351831489744,"E2F1/EP300/TP53",3
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","2/33","10/2914",0.00528879182577272,0.0255736516132301,0.0168423883592229,"NFKB1/RELA",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/33","10/2914",0.00528879182577272,0.0255736516132301,0.0168423883592229,"TP53/TP73",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/33","10/2914",0.00528879182577272,0.0255736516132301,0.0168423883592229,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/33","10/2914",0.00528879182577272,0.0255736516132301,0.0168423883592229,"STAT3/STAT1",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/33","10/2914",0.00528879182577272,0.0255736516132301,0.0168423883592229,"EP300/FOXO1",2
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/33","107/2914",0.00634784222147887,0.0285098124036762,0.0187760957963037,"EP300/NR3C1/PARP1/TP53/RELA",5
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"STAT3/STAT1",2
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"NFKB1/RELA",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"EP300/MAML1",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"SMAD4/STAT3",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"E2F1/TP53",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/33","11/2914",0.00641843944166532,0.0285098124036762,0.0187760957963037,"STAT3/STAT1",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/33","109/2914",0.00686416832371015,0.0301392218351411,0.0198491981774559,"EP300/NR3C1/PARP1/TP53/RELA",5
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/33","110/2914",0.00713316697738215,0.0309644293790907,0.0203926663587839,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/33","36/2914",0.00732762028709899,0.0314511342659755,0.0207132022308298,"CDK8/PARP1/SMAD4",3
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/33","12/2914",0.00764778244825432,0.0324605877248128,0.021378011755939,"STAT3/STAT1",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","4/33","72/2914",0.00815787075388425,0.0342451277800416,0.0225532806267014,"CHUK/EP300/NFKB1/RELA",4
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","3/33","38/2914",0.00852555522665873,0.0353995880063439,0.0233135892353711,"CHUK/NFKB1/RELA",3
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/33","13/2914",0.00897455787783281,0.0360871695719172,0.0237664192000226,"NFKB1/RELA",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/33","13/2914",0.00897455787783281,0.0360871695719172,0.0237664192000226,"EP300/TP53",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/33","13/2914",0.00897455787783281,0.0360871695719172,0.0237664192000226,"EP300/FOXO1",2
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","3/33","39/2914",0.0091653057339293,0.0364702790662604,0.0240187288422051,"CHUK/NFKB1/RELA",3
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/33","40/2914",0.00983260084588423,0.0387222012693585,0.0255018079453753,"EP300/MAML1/NOTCH1",3
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","2/33","14/2914",0.0103965385533922,0.0397147772739582,0.0261555022553762,"CHUK/NFKB1",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/33","14/2914",0.0103965385533922,0.0397147772739582,0.0261555022553762,"EP300/TP53",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/33","14/2914",0.0103965385533922,0.0397147772739582,0.0261555022553762,"SMAD4/FOXO1",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/33","15/2914",0.0119115326068277,0.0440846596537157,0.0290334352638139,"TP53/TP73",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/33","15/2914",0.0119115326068277,0.0440846596537157,0.0290334352638139,"EP300/TP53",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/33","15/2914",0.0119115326068277,0.0440846596537157,0.0290334352638139,"CASP1/STAT3",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","3/33","43/2914",0.0120021062931582,0.0440846596537157,0.0290334352638139,"CHUK/NFKB1/RELA",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/33","127/2914",0.0129155959232752,0.0469881680256296,0.0309456383525089,"CHUK/HMGB1/NFKB1/RELA/MEF2C",5
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/33","46/2914",0.014427257823207,0.0519925706458968,0.0342414560054266,"NR3C1/NR4A1/NR2F1",3
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","2/33","17/2914",0.0152119670695438,0.0543081441174366,0.0357664547921393,"CHUK/RELA",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/33","49/2914",0.0171123733848971,0.0605270984539879,0.0398621563254425,"EP300/MYB/POU2F1",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","6/33","194/2914",0.0196587673805354,0.0688958636638948,0.0453736881115207,"CASP1/E2F1/EP300/PIDD1/TP53/TP73",6
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/33","20/2914",0.0208074002962801,0.0722584264834455,0.0475882169455593,"PARP1/SMAD4",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","3/33","53/2914",0.0211020701260786,0.0726215386320904,0.0478273566631844,"CHUK/NFKB1/RELA",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/33","97/2914",0.0225236206591149,0.0768216347480526,0.0505934712173727,"CHUK/EGFR/NR4A1/FOXO1",4
"R-HSA-525793","R-HSA-525793","Myogenesis","2/33","22/2914",0.0249439462750454,0.0843237829828967,0.0555342632485872,"CTNNB1/MEF2C",2
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","2/33","23/2914",0.0271282227490366,0.0909033428958945,0.0598674537120936,"E2F1/TP53",2
"R-HSA-202403","R-HSA-202403","TCR signaling","3/33","59/2914",0.0279713857756678,0.0927764285132109,0.0611010372407203,"CHUK/NFKB1/RELA",3
"R-HSA-450294","R-HSA-450294","MAP kinase activation","3/33","60/2914",0.0292196371861816,0.0927764285132109,0.0611010372407203,"CHUK/NFKB1/MEF2C",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/33","24/2914",0.0293872980369071,0.0927764285132109,0.0611010372407203,"EP300/HIF1A",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/33","24/2914",0.0293872980369071,0.0927764285132109,0.0611010372407203,"STAT3/STAT1",2
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/33","24/2914",0.0293872980369071,0.0927764285132109,0.0611010372407203,"CDK8/SMAD4",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/33","24/2914",0.0293872980369071,0.0927764285132109,0.0611010372407203,"STAT3/STAT1",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/33","24/2914",0.0293872980369071,0.0927764285132109,0.0611010372407203,"STAT3/STAT1",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/33","25/2914",0.031719308115928,0.0983588938162782,0.0647775575147162,"EGFR/EP300",2
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","3/33","62/2914",0.0318045008464878,0.0983588938162782,0.0647775575147162,"NR3C1/SMAD4/STAT1",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","4/33","108/2914",0.0319280178880065,0.0983588938162782,0.0647775575147162,"EGFR/EP300/MYB/POU2F1",4
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/33","63/2914",0.0331410068167205,0.100475115904661,0.0661712667434938,"CDK8/PARP1/SMAD4",3
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","3/33","63/2914",0.0331410068167205,0.100475115904661,0.0661712667434938,"CHUK/NFKB1/RELA",3
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/33","26/2914",0.0341224193445257,0.101044683640378,0.0665463747314699,"MAML1/NOTCH1",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/33","26/2914",0.0341224193445257,0.101044683640378,0.0665463747314699,"CTNNB1/HMGB1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/33","26/2914",0.0341224193445257,0.101044683640378,0.0665463747314699,"NR3C1/STAT1",2
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","3/33","64/2914",0.0345068080055336,0.101396928139337,0.0667783571928949,"CHUK/NFKB1/MEF2C",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/33","27/2914",0.036594828046502,0.10671163598293,0.0702785367867737,"MYB/TP73",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/33","68/2914",0.0402612718713919,0.116513680718725,0.0767340030084742,"E2F1/EP300/TP53",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/33","29/2914",0.0417404705336862,0.118262415969529,0.0778856914211006,"STAT3/STAT1",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/33","29/2914",0.0417404705336862,0.118262415969529,0.0778856914211006,"EP300/MAML1",2
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","5/33","172/2914",0.0417943093086031,0.118262415969529,0.0778856914211006,"CHUK/EGFR/NR4A1/TP53/FOXO1",5
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/33","428/2914",0.0431340645152825,0.121155975329691,0.0797913422535025,"CASP1/CHUK/CTNNB1/EP300/HMGB1/PRKDC/NFKB1/RELA/MEF2C",9
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/33","30/2914",0.0444102431225022,0.123830020969313,0.0815524249425895,"STAT3/TP53",2
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","2/33","31/2914",0.0471423899955802,0.127719099136962,0.0841137081668061,"NFKB1/RELA",2
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/33","31/2914",0.0471423899955802,0.127719099136962,0.0841137081668061,"CTNNB1/LEF1",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/33","31/2914",0.0471423899955802,0.127719099136962,0.0841137081668061,"STAT3/TP53",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/33","31/2914",0.0471423899955802,0.127719099136962,0.0841137081668061,"STAT3/STAT1",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","4/33","124/2914",0.0492459054362769,0.132478421666604,0.0872481200835446,"EP300/SMAD4/TP53/HIF1A",4
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/33","32/2914",0.0499352512436155,0.133393468357071,0.0878507548562687,"STAT3/STAT1",2
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/33","33/2914",0.0527871945332302,0.140032696608986,0.0922232419111259,"CASP1/CHUK",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/33","80/2914",0.0602540638535272,0.158738292358948,0.104542441096138,"SMAD4/TP53/HIF1A",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","3/33","81/2914",0.0620991779094754,0.162478670968627,0.107005793225412,"PARP1/PRKDC/TP53",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/33","37/2914",0.0647540853801097,0.168035980415224,0.110665746264091,"CTNNB1/LEF1",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","4/33","136/2914",0.0651029452917621,0.168035980415224,0.110665746264091,"EGFR/EP300/MYB/POU2F1",4
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","8/33","393/2914",0.0666442811899314,0.170859834997005,0.112525490670389,"EP300/NR3C1/PARP1/PRKDC/SMAD4/TP53/HIF1A/RELA",8
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","3/33","86/2914",0.0717206971428201,0.181439114626207,0.119492831070993,"EP300/MYB/TP73",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/33","86/2914",0.0717206971428201,0.181439114626207,0.119492831070993,"CDK8/PARP1/SMAD4",3
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","5/33","201/2914",0.0727268798704356,0.182774132305963,0.120372051863117,"CHUK/EGFR/NR4A1/TP53/FOXO1",5
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/33","87/2914",0.0737226692046014,0.184065749255933,0.121222689644993,"CHUK/NFKB1/RELA",3
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/33","40/2914",0.07427359569817,0.184237101017539,0.121335539110476,"CTNNB1/LEF1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/33","41/2914",0.0775426167777883,0.189879997494328,0.125051858366339,"STAT3/STAT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/33","41/2914",0.0775426167777883,0.189879997494328,0.125051858366339,"STAT3/STAT1",2
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","2/33","42/2914",0.0808572084436366,0.196735373410632,0.129566696735026,"LIF/STAT3",2
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","2/33","44/2914",0.0876176200417457,0.211835005417385,0.1395110672217,"E2F1/TP53",2
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","3/33","95/2914",0.0906311737392524,0.217407557285389,0.143181058669628,"EP300/TP53/TP73",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/33","45/2914",0.0910607569781735,0.217407557285389,0.143181058669628,"STAT3/STAT1",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/33","47/2914",0.0980663584276971,0.232519406009074,0.153133474886109,"CDK8/EP300",2
"R-HSA-73894","R-HSA-73894","DNA Repair","4/33","157/2914",0.0986077062132724,0.232519406009074,0.153133474886109,"EP300/PARP1/PRKDC/TP53",4
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/33","48/2914",0.101626276817433,0.238167102725519,0.156852955501237,"CDK8/EP300",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/33","49/2914",0.105222613133711,0.245091696445596,0.161413379582523,"STAT3/STAT1",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/33","10/2914",0.107804312968026,0.24512647353444,0.161436283203999,"E2F1",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/33","10/2914",0.107804312968026,0.24512647353444,0.161436283203999,"E2F1",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/33","10/2914",0.107804312968026,0.24512647353444,0.161436283203999,"RELA",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/33","10/2914",0.107804312968026,0.24512647353444,0.161436283203999,"EP300",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","3/33","106/2914",0.116293467665341,0.248918165317641,0.163933429349452,"CHUK/NFKB1/RELA",3
"R-HSA-110373","R-HSA-110373","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"PARP1",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"E2F1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"E2F1",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"PRKDC",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"FOXO1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"TP53",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"CEBPB",1
"R-HSA-5686938","R-HSA-5686938","Regulation of TLR by endogenous ligand","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"HMGB1",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"EGFR",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/33","11/2914",0.117942900320662,0.248918165317641,0.163933429349452,"FOXO1",1
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","3/33","108/2914",0.121234890113296,0.253287236069091,0.166810827832772,"CTNNB1/EP300/LEF1",3
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","3/33","109/2914",0.123735420082406,0.253287236069091,0.166810827832772,"EP300/NFKB1/RELA",3
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","3/33","109/2914",0.123735420082406,0.253287236069091,0.166810827832772,"EP300/NFKB1/RELA",3
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/33","55/2914",0.127498669803721,0.253287236069091,0.166810827832772,"EP300/PARP1",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"SMAD4",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"NOTCH1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"CTNNB1",1
"R-HSA-933543","R-HSA-933543","NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"CHUK",1
"R-HSA-937039","R-HSA-937039","IRAK1 recruits IKK complex","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"CHUK",1
"R-HSA-975144","R-HSA-975144","IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation","1/33","12/2914",0.127969729218154,0.253287236069091,0.166810827832772,"CHUK",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"EP300",1
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"CHUK",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"NOTCH1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"POU2F1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/33","13/2914",0.137885993496514,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CEBPB",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"CTNNB1",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"EGFR",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"STAT1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/33","14/2914",0.147692874645985,0.259993908362978,0.171227732429737,"EP300",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/33","62/2914",0.154763050107901,0.268408790263292,0.176769635913273,"MYB/TP53",2
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"SMAD4",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"NR3C1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"EP300",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"E2F1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/33","15/2914",0.157391541934496,0.268408790263292,0.176769635913273,"CTNNB1",1
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"EGFR",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"CTNNB1",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"EGFR",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"EGFR",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"TP53",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"EGFR",1
"R-HSA-5676590","R-HSA-5676590","NIK-->noncanonical NF-kB signaling","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"CHUK",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"LIF",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"PARP1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/33","16/2914",0.166983152529929,0.271436443686949,0.178763598901022,"EP300",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/33","66/2914",0.170831338001543,0.276515131849955,0.182108339796471,"EP300/TP53",2
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","1/33","17/2914",0.176468851621204,0.282054817235564,0.185756685917056,"CHUK",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/33","17/2914",0.176468851621204,0.282054817235564,0.185756685917056,"EGFR",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/33","17/2914",0.176468851621204,0.282054817235564,0.185756685917056,"PARP1",1
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/33","18/2914",0.185849772538187,0.292158901685544,0.192411070550689,"HIF1A",1
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","1/33","18/2914",0.185849772538187,0.292158901685544,0.192411070550689,"EGFR",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/33","18/2914",0.185849772538187,0.292158901685544,0.192411070550689,"EP300",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/33","18/2914",0.185849772538187,0.292158901685544,0.192411070550689,"E2F1",1
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","2/33","70/2914",0.187180391058274,0.293044710591233,0.192994449796927,"STAT3/MEF2C",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/33","19/2914",0.195127036870452,0.300558580985938,0.197942961850755,"E2F1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/33","19/2914",0.195127036870452,0.300558580985938,0.197942961850755,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/33","19/2914",0.195127036870452,0.300558580985938,0.197942961850755,"CTNNB1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/33","19/2914",0.195127036870452,0.300558580985938,0.197942961850755,"EP300",1
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"EGFR",1
"R-HSA-5357905","R-HSA-5357905","Regulation of TNFR1 signaling","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"CHUK",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"GAPDH",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"GAPDH",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"EP300",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"EGFR",1
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","1/33","20/2914",0.204301754584882,0.306052040201666,0.201560864172494,"CHUK",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/33","76/2914",0.212112167383236,0.312296012345964,0.205673042024485,"NFKB1/RELA",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/33","76/2914",0.212112167383236,0.312296012345964,0.205673042024485,"CTNNB1/LEF1",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/33","21/2914",0.213375024142138,0.312296012345964,0.205673042024485,"CTNNB1",1
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","1/33","21/2914",0.213375024142138,0.312296012345964,0.205673042024485,"MEF2C",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/33","21/2914",0.213375024142138,0.312296012345964,0.205673042024485,"NOTCH1",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/33","21/2914",0.213375024142138,0.312296012345964,0.205673042024485,"PARP1",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"EGFR",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"STAT3",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"EGFR",1
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"CHUK",1
"R-HSA-5696400","R-HSA-5696400","Dual Incision in GG-NER","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"PARP1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"TP53",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"PRKDC",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/33","22/2914",0.222347932611999,0.314581149102903,0.207177995689153,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/33","23/2914",0.231221555787589,0.324730273201688,0.213862042698273,"SMAD4",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/33","23/2914",0.231221555787589,0.324730273201688,0.213862042698273,"E2F1",1
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"MEF2C",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"TP53",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"TP53",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"EGFR",1
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"SMAD4",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"STAT1",1
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","1/33","24/2914",0.239996958298488,0.328597985914059,0.216409254983356,"EGFR",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/33","25/2914",0.248675193722761,0.339264014293196,0.223433726690752,"CTNNB1",1
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/33","26/2914",0.25725730469789,0.349723453361545,0.230322142059546,"EGFR",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"NOTCH1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"EP300",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"EP300",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"TP53",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"PRKDC",1
"R-HSA-75893","R-HSA-75893","TNF signaling","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"CHUK",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/33","27/2914",0.265744323030636,0.352480317353136,0.232137767559657,"PRKDC",1
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","2/33","89/2914",0.267108773854744,0.353064192430838,0.232522298128879,"STAT3/MEF2C",2
"R-HSA-1236974","R-HSA-1236974","ER-Phagosome pathway","1/33","28/2914",0.274137269805832,0.356191962808938,0.234582196504095,"CHUK",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/33","28/2914",0.274137269805832,0.356191962808938,0.234582196504095,"SMAD4",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/33","28/2914",0.274137269805832,0.356191962808938,0.234582196504095,"NR3C1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/33","28/2914",0.274137269805832,0.356191962808938,0.234582196504095,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/33","28/2914",0.274137269805832,0.356191962808938,0.234582196504095,"EP300",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/33","29/2914",0.282437155494123,0.363269338042946,0.239243239989705,"CEBPB",1
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","1/33","29/2914",0.282437155494123,0.363269338042946,0.239243239989705,"TP53",1
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","1/33","29/2914",0.282437155494123,0.363269338042946,0.239243239989705,"TP53",1
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","1/33","30/2914",0.290644980058661,0.370087941274695,0.243733860470246,"MEF2C",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/33","30/2914",0.290644980058661,0.370087941274695,0.243733860470246,"CTNNB1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/33","30/2914",0.290644980058661,0.370087941274695,0.243733860470246,"PARP1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/33","31/2914",0.298761733060764,0.379159408734923,0.249708180456453,"CTNNB1",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/33","32/2914",0.306788393764543,0.385503836901498,0.253886517000435,"MEF2C",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/33","32/2914",0.306788393764543,0.385503836901498,0.253886517000435,"EP300",1
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","1/33","32/2914",0.306788393764543,0.385503836901498,0.253886517000435,"TP53",1
"R-HSA-195721","R-HSA-195721","Signaling by WNT","3/33","172/2914",0.308506970494612,0.386392336816202,0.254471668501164,"CTNNB1/EP300/LEF1",3
"R-HSA-1236975","R-HSA-1236975","Antigen processing-Cross presentation","1/33","33/2914",0.314725931240521,0.391613373725991,0.257910157951259,"CHUK",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/33","33/2914",0.314725931240521,0.391613373725991,0.257910157951259,"EP300",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/33","34/2914",0.322575304468242,0.39494796893227,0.260106267772975,"STAT1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/33","34/2914",0.322575304468242,0.39494796893227,0.260106267772975,"EP300",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/33","34/2914",0.322575304468242,0.39494796893227,0.260106267772975,"FOXO1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/33","34/2914",0.322575304468242,0.39494796893227,0.260106267772975,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/33","34/2914",0.322575304468242,0.39494796893227,0.260106267772975,"TP53",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/33","35/2914",0.330337462437876,0.399331995731863,0.262993516064798,"STAT1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/33","35/2914",0.330337462437876,0.399331995731863,0.262993516064798,"CTNNB1",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/33","35/2914",0.330337462437876,0.399331995731863,0.262993516064798,"TP53",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/33","35/2914",0.330337462437876,0.399331995731863,0.262993516064798,"TP53",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/33","37/2914",0.345603879219482,0.415159376924032,0.273417170253082,"EP300",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/33","37/2914",0.345603879219482,0.415159376924032,0.273417170253082,"EP300",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/33","38/2914",0.35310998696566,0.421525046940257,0.277609496331555,"MEF2C",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/33","38/2914",0.35310998696566,0.421525046940257,0.277609496331555,"PARP1",1
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","5/33","347/2914",0.356029782062191,0.423686531924476,0.279033014962661,"CTNNB1/EGFR/STAT3/STAT1/MEF2C",5
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/33","39/2914",0.360532577518558,0.426388373412041,0.280812403542237,"EP300",1
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","1/33","39/2914",0.360532577518558,0.426388373412041,0.280812403542237,"E2F1",1
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","1/33","40/2914",0.367872551411389,0.430969860653336,0.283829696048904,"E2F1",1
"R-HSA-69236","R-HSA-69236","G1 Phase","1/33","40/2914",0.367872551411389,0.430969860653336,0.283829696048904,"E2F1",1
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","1/33","40/2914",0.367872551411389,0.430969860653336,0.283829696048904,"E2F1",1
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","3/33","191/2914",0.368919226266076,0.430969860653336,0.283829696048904,"E2F1/EP300/TP53",3
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/33","41/2914",0.375130799777229,0.436890138764943,0.287728694309235,"MEF2C",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/33","42/2914",0.382308204443902,0.442550709386577,0.2914566534676,"CTNNB1",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/33","42/2914",0.382308204443902,0.442550709386577,0.2914566534676,"STAT1",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","2/33","119/2914",0.393104479845357,0.452041654503133,0.297707234572193,"CDK8/EP300",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/33","44/2914",0.396423964027617,0.452041654503133,0.297707234572193,"EGFR",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/33","44/2914",0.396423964027617,0.452041654503133,0.297707234572193,"EGFR",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/33","44/2914",0.396423964027617,0.452041654503133,0.297707234572193,"EGFR",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/33","44/2914",0.396423964027617,0.452041654503133,0.297707234572193,"GAPDH",1
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","1/33","45/2914",0.403364036915104,0.45858649434991,0.302017558968389,"CHUK",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/33","46/2914",0.410226702227687,0.463628994825374,0.305338467245149,"PARP1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/33","46/2914",0.410226702227687,0.463628994825374,0.305338467245149,"TP53",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/33","47/2914",0.417012796658122,0.468962067650097,0.308850741714999,"STAT1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/33","125/2914",0.417400793196421,0.468962067650097,0.308850741714999,"HMGB1/NFKB1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","1/33","49/2914",0.43035857595681,0.482102568960414,0.317504860792337,"EP300",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/33","51/2914",0.443407894840387,0.493824535944688,0.325224756381318,"E2F1",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/33","51/2914",0.443407894840387,0.493824535944688,0.325224756381318,"HIF1A",1
"R-HSA-373760","R-HSA-373760","L1CAM interactions","1/33","53/2914",0.456167137461033,0.505089410174245,0.332643618163804,"EGFR",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/33","53/2914",0.456167137461033,0.505089410174245,0.332643618163804,"EGFR",1
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","1/33","56/2914",0.474775746750004,0.524174379359831,0.345212666483879,"TP53",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/33","57/2914",0.480840267518811,0.529340006317538,0.348614663846491,"CTNNB1",1
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","1/33","59/2914",0.492766268262019,0.540910099069227,0.356234537551792,"TP53",1
"R-HSA-69206","R-HSA-69206","G1/S Transition","1/33","60/2914",0.498629215073701,0.545777536269782,0.359440152021157,"E2F1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/33","62/2914",0.510158611036638,0.555215354461527,0.365655744602659,"STAT3",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/33","62/2914",0.510158611036638,0.555215354461527,0.365655744602659,"TP53",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/33","63/2914",0.515826481245541,0.558203161007923,0.367623465089263,"PARP1",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","1/33","63/2914",0.515826481245541,0.558203161007923,0.367623465089263,"EGFR",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/33","66/2914",0.532451150943601,0.574565931244225,0.378399717738688,"EGFR",1
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","3/33","249/2914",0.544997541483156,0.58644805872272,0.386225092407633,"E2F1/EP300/TP53",3
"R-HSA-69242","R-HSA-69242","S Phase","1/33","71/2914",0.558936450666511,0.599757652119683,0.394990572765512,"E2F1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/33","72/2914",0.564056076810727,0.603555802077584,0.397491972159115,"EGFR",1
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","1/33","77/2914",0.588802008390683,0.628274768729723,0.413771478992571,"E2F1",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","1/33","80/2914",0.602989861754302,0.641621524206527,0.422561433687958,"MEF2C",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","1/33","85/2914",0.62558793228594,0.663818305925636,0.43717987080801,"CTNNB1",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","3/33","289/2914",0.650017539938975,0.687830194616866,0.452993707669967,"CDK8/EP300/GAPDH",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","1/33","92/2914",0.655141236013964,0.689432375089076,0.454048877504241,"CTNNB1",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","1/33","92/2914",0.655141236013964,0.689432375089076,0.454048877504241,"EGFR",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","3/33","296/2914",0.666646106399067,0.699612122649571,0.460753092623994,"CHUK/NFKB1/RELA",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","1/33","97/2914",0.674852392471513,0.706283873764707,0.46514699870423,"STAT1",1
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","2/33","202/2914",0.678642324330485,0.708309748344932,0.466481206542956,"EGFR/FOXO1",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","1/33","99/2914",0.682427050527621,0.710319164309404,0.467804575006745,"EGFR",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","1/33","114/2914",0.734030658458821,0.761955737856711,0.501811577150052,"TP53",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/33","115/2914",0.737165297126985,0.7631358902507,0.502588806199827,"CHUK",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/33","126/2914",0.769366342768833,0.794318764696471,0.523125336903986,"CTNNB1",1
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","1/33","130/2914",0.780099196557111,0.803228822331042,0.528993355020995,"CTNNB1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/33","144/2914",0.813981984756079,0.835863220905436,0.550485835757507,"EGFR",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/33","160/2914",0.846521423640095,0.866946873540258,0.570957020601052,"EGFR",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","1/33","165/2914",0.855505390642466,0.873804971190968,0.575473651459469,"EGFR",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","1/33","171/2914",0.865614327724722,0.879972818141046,0.579535694504574,"EGFR",1
"R-HSA-109582","R-HSA-109582","Hemostasis","2/33","298/2914",0.866151255552443,0.879972818141046,0.579535694504574,"MYB/TP53",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","1/33","177/2914",0.875036002593039,0.886641254616819,0.58392741761758,"EGFR",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","1/33","188/2914",0.89067262630144,0.90009773345807,0.592789634324824,"EGFR",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","1/33","228/2914",0.933071472364442,0.940457262383158,0.619369759464246,"CTNNB1",1
"R-HSA-422475","R-HSA-422475","Axon guidance","1/33","254/2914",0.951541973667021,0.9565500893179,0.629968231873734,"EGFR",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","1/33","436/2914",0.995395004612387,0.997660246420932,0.657042708444758,"EGFR",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","1/33","486/2914",0.997660246420932,0.997660246420932,0.657042708444758,"EGFR",1
